Zoledronic Acid News and Research

RSS
Zoledronic acid is a drug used to treat patients with hypercalcemia (high blood levels of calcium) caused by cancer. It is also used together with other drugs to treat multiple myeloma and to prevent bone fractures and reduce bone pain in people who have cancer that has spread to the bone. It is a type of bisphosphonate. Also called zoledronate and Zometa.
Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Microscopic imaging helps better understand cancer bone metastasis

Microscopic imaging helps better understand cancer bone metastasis

Osteoporosis drug prevents spread of basal-like breast cancer in mice

Osteoporosis drug prevents spread of basal-like breast cancer in mice

Researchers identify potential 'first-line' treatment for rare bone loss disease

Researchers identify potential 'first-line' treatment for rare bone loss disease

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Two new treatments may benefit patients with high risk prostate cancer, trial shows

Two new treatments may benefit patients with high risk prostate cancer, trial shows

New therapeutic approach offers hope for individuals with debilitating bone cancer

New therapeutic approach offers hope for individuals with debilitating bone cancer

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

New guidelines recommend evaluation of osteoporosis risk for all postmenopausal women

New guidelines recommend evaluation of osteoporosis risk for all postmenopausal women

Single dose of zoledronic acid can inhibit bone loss in HIV-infected patients

Single dose of zoledronic acid can inhibit bone loss in HIV-infected patients

Lancet study compares prices of new cancer drugs in high-income countries

Lancet study compares prices of new cancer drugs in high-income countries

Mount Sinai Health System researchers present updates on cancer vaccine clinical trials at ASCO 2015

Mount Sinai Health System researchers present updates on cancer vaccine clinical trials at ASCO 2015

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Osteoporosis drugs may not protect women from breast cancer

Osteoporosis drugs may not protect women from breast cancer

Women with metastatic breast cancer can receive bisphosphonates less frequently and safely

Women with metastatic breast cancer can receive bisphosphonates less frequently and safely

Study compares efficacy and side effects of popular osteoporosis drugs

Study compares efficacy and side effects of popular osteoporosis drugs

Risks of developing kidney failure, calcium deficiency from zoledronic acid are extremely rare

Risks of developing kidney failure, calcium deficiency from zoledronic acid are extremely rare

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Zometa does not prevent bone metastases

Zometa does not prevent bone metastases

Dr. Reddy's launches generic Zometa

Dr. Reddy's launches generic Zometa